![Gregory Sahak Petros](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Sahak Petros
Director/Board Member at
Quotient Sciences Ltd.
Profile
Gregory Sahak Petros is currently a Non-Executive Director at QS Pharma LLC, Quotient Sciences Ltd., and Quad UK Topco Ltd. He is also a Principal at Bain Capital Ltd. starting in 2022.
Previously, he was a Director at Corin Group Ltd. from 2019 to 2021, an Investment Professional at Permira Advisers LLP from 2014 to 2021, and a Consultant at The Boston Consulting Group Ltd. from 2012 to 2014.
He obtained an undergraduate degree from the University of Oxford.
Gregory Sahak Petros active positions
| Companies | Position | Start |
|---|---|---|
Quotient Sciences Ltd.
 Quotient Sciences Ltd. Pharmaceuticals: MajorHealth Technology Engages in contract research and contract manufacturing of stages of small molecule and synthetic peptide drugs | Director/Board Member | - |
QS Pharma LLC
 QS Pharma LLC Medical SpecialtiesHealth Technology Provides a broad range of contract research services for pharmaceutical and biopharmaceutical companies | Director/Board Member | - |
Quad UK Topco Ltd.
 Quad UK Topco Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries engages in research, development and manufacturing of pharmaceutical activities | Director/Board Member | 31/07/2019 |
Former positions of Gregory Sahak Petros
| Companies | Position | End |
|---|---|---|
Permira Advisers LLP
 Permira Advisers LLP Investment ManagersFinance Permira Advisers invests in middle market companies located across the globe. The firm focuses on technology, consumer, healthcare, services and climate sectors. It provides financing in the form of debt and equity for buyout and growth stage capital requirements. | Private Equity Investor | 31/12/2021 |
| CORIN GROUP PLC | Director/Board Member | 01/11/2021 |
The Boston Consulting Group Ltd.
 The Boston Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Consultant / Advisor | 01/10/2014 |
Bain Capital Ltd.
 Bain Capital Ltd. Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | - |
Training of Gregory Sahak Petros
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
83
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Corin Group Ltd.
 Corin Group Ltd. Medical SpecialtiesHealth Technology Designs and manufactures orthopedic devices | Health Technology |
Permira Advisers LLP
Permira Advisers LLP Investment ManagersFinance Permira Advisers invests in middle market companies located across the globe. The firm focuses on technology, consumer, healthcare, services and climate sectors. It provides financing in the form of debt and equity for buyout and growth stage capital requirements. | Finance |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QS Pharma LLC
QS Pharma LLC Medical SpecialtiesHealth Technology Provides a broad range of contract research services for pharmaceutical and biopharmaceutical companies | Health Technology |
Bain Capital Ltd.
Bain Capital Ltd. Investment ManagersFinance Acts as an alternative investment manager | Finance |
The Boston Consulting Group Ltd.
The Boston Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Quotient Sciences Ltd.
Quotient Sciences Ltd. Pharmaceuticals: MajorHealth Technology Engages in contract research and contract manufacturing of stages of small molecule and synthetic peptide drugs | Health Technology |
Quad UK Topco Ltd.
Quad UK Topco Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries engages in research, development and manufacturing of pharmaceutical activities | Health Technology |
- Stock Market
- Insiders
- Gregory Sahak Petros
